Biotech · Private company
NX Development Corp
Track this companyFree. Adds NX Development Corp to your Dealase workspace and tells you when its record changes.
Clinical trials42 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- GleolanPhase 3 · MeningiomaClinicalTrials.gov · fetched Nov 12, 2026
- GleolanPhase 3 · Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- A Multicenter Study to Assess the Feasibility of 5-Aminolevulinic Acid (5-ALA) in Pediatric Brain Tumor PatientsPHASE2 · NOT_YET_RECRUITING · started Aug 1, 2027ClinicalTrials.gov NCT06907485 · fetched Nov 12, 2026
- Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)PHASE3 · RECRUITING · started May 30, 2024ClinicalTrials.gov NCT05804370 · fetched Nov 12, 2026
- The Role of 5-Aminolevulinic Acid Fluorescence-Guided Surgery in Head and Neck Cancers: a Pilot TrialPHASE2 · TERMINATED · started Sep 14, 2021ClinicalTrials.gov NCT05101798 · fetched Nov 12, 2026
- Gleolan for Visualization of Newly Diagnosed or Recurrent MeningiomaPHASE3 · COMPLETED · started Oct 28, 2020ClinicalTrials.gov NCT04305470 · fetched Nov 12, 2026